3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
10
Overweight
4
Obesity
4
Neoplasms
4
Prostatic Neoplasms
3
Motor Activity
3
Colorectal Neoplasms
3
Sleep Wake Disorders
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Lymphoma
2
Leukemia
2
Hematopoietic and Lymphoid System Neoplasm
2
Hematologic Neoplasms
2
Fatigue
2
Colonic Neoplasms
2
Breast Carcinoma In Situ
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Obesity-Related Malignant Neoplasm
1
No Evidence of Disease
1
Neoplasm Metastasis
1
Metastatic Pancreatic Adenocarcinoma
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Leukemia, Myeloid, Acute
1
Interventions
Specimen Handling
9
Tamoxifen
8
Radiotherapy
6
exemestane
3
Radiation Dose Hypofractionation
3
Radiation
3
Letrozole
3
Anastrozole
3
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Patient Navigation
2
Observation
2
Metformin
2
Mastectomy
2
Magnetic Resonance Spectroscopy
2
Genetic Testing
2
Biopsy
2
trastuzumab biosimilar HLX02
1
ruxolitinib
1
poly ICLC
1
palbociclib
1
fezolinetant
1
elacestrant
1
afimoxifene
1
abemaciclib
1
Trastuzumab
1
Testosterone
1
Tablets
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
Counseling
×
1 year
×
Clear all
NCT01819233
2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA
Completed
38 enrolled
10 charts